Published in Nature nature.com/articles/d42473-... - a new platform designed to forecast ‘cytokine storms’.
Caveat: article is a paid-for advertisement and method is not yet tested in human subjects. Claims of accuracy and reliability are based on mouse studies.
"Immunotherapies have become powerful tools for treating serious diseases, from cancer to immune disorders. But in some patients, these drugs can trigger cytokine release syndrome, a condition with symptoms ranging from mild fever to life-threatening organ failure".
Projected use as a screening tool for cytokine release syndrome, of:
- treatments before they make it to the clinic
- patients before they are given certain drugs
Potential use to evaluate drugs for inhibiting cytokine release syndrome in patients with severe COVID-19.
LLR response to the proposed cuts sorry Bloodwise 
Anti Covid treatments for the Immuno-compromised
What questions do you want Andrew Schorr of Patient Power to ask CLL world experts at the International Workshop on CLL?
Coronavirus (COVID-19) Supply Chain Update - FDA Statement - February 27, 2020
